The value of mRNA expression of S100A8 and S100A9 as blood-based biomarkers of inflammatory bowel disease

ConclusionThe S100A8 and S100A9 mRNA are differentially expressed in blood leucocytes of IBD patients compared to healthy controls as well as active versus quiescent disease. Thus, they can be potentially used as a blood-based biomarker in the monitoring of IBD.
Source: Arab Journal of Gastroenterology - Category: Gastroenterology Source Type: research